The Department of Justice took a crucial step in May toward reclassifying marijuana, formalizing a process to move it from a Schedule I to a Schedule III substance. This momentous policy change could have profound implications for the cannabis industry nationwide, including New Jersey, where the Benzinga Cannabis Market Spotlight is set to take place on June 17. Potential Pharmaceutical Entry Raises ConcernsDr. Chanda Macias, CEO of Women Grow and National Holistic, shared her thoughts on how the rescheduling could affect the cannabis market in New Jersey. According to Macias, the reclassifica…
